Comment on the Effect of Endocannabinoid System on Rat Behavior

Comment

Ali Roohbakhsh. Basic Clin Neurosci. 2017 Jan.

. 2017 Jan;8(1):85.

doi: 10.15412/J.BCN.03080111.

No abstract available

Comment on

The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases.
Ninis N, Phillips C, Bailey L, Pollock JI, Nadel S, Britto J, Maconochie I, Winrow A, Coen PG, Booy R, Levin M. Ninis N, et al. BMJ. 2005 Jun 25;330(7506):1475. doi: 10.1136/bmj.330.7506.1475. BMJ. 2005. PMID: 15976421 Free PMC article.

1. Henstridge C. M., Balenga N. A., Schröder R., Kargl J. K., Platzer W., Martini L., et al. (2010). GPR55 ligands promote receptor coupling to multiple signaling pathways. British Journal of Pharmacology, 160(3), 604–14. doi: 10.1111/j.1476-5381.2009.00625.x - DOI - PMC - PubMed
1. Kargl J., Balenga N., Parzmair G. P., Brown A. J., Heinemann A., Waldhoer M. (2012). The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55. Journal of Biological Chemistry, 287(53), 44234–248. doi: 10.1074/jbc.m112.364109 - DOI - PMC - PubMed
1. Komaki A., Hashemi-Firouzi N., Shojaei Sh., Souri Z., Heidari S., Shahidi S. (2015). Study the effect of endocannabinoid system on rat behavior in elevated plus-maze. Basic and Clinical Neuroscience, 6(3), 147–154. - PMC - PubMed
1. Lauckner J. E., Jensen J. B., Chen H. Y., Lu H. C., Hille B., Mackie K. (2008). GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proceedings of National Academy of Science USA, 105(7), 2699–704. doi: 10.1073/pnas.0711278105 - DOI - PMC - PubMed
1. Rahimi A., Hajizadeh Moghaddam A., Roohbakhsh A. (2015). Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats. Fundamental and Clinical Pharmacology, 29(2), 185–90. doi: 10.1111/fcp.12099 - DOI - PubMed